Ermina Use In Pregnancy & Lactation

Pregnancy: Drospirenone + Ethinylestradiol is not indicated during pregnancy. If pregnancy occurs during treatment with Drospirenone + Ethinylestradiol, further intake must be stopped. However, extensive epidemiological studies have revealed neither an increased risk of birth defects in children born to women who used COCs prior to pregnancy, nor a teratogenic effect when COCs were taken inadvertently during early pregnancy.
The available data regarding the use of drospirenone + ethinylestradiol during pregnancy are too limited to permit conclusions concerning negative effects of Drospirenone + Ethinylestradiol on pregnancy, health of the fetus or neonate. No relevant epidemiological data are available yet.
Lactation: Lactation may be influenced by COCs as they may reduce the quantity and change the composition of breast milk. Therefore, the use of COCs should generally not be recommended until the nursing mother has completely weaned her child. Small amounts of the contraceptive steroids and/or their metabolites may be excreted with the milk.